Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.
about
Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndromeSphingolipids in High Fat Diet and Obesity-Related DiseasesRegulation of Nlrp3 inflammasome by dietary metabolitesFunctional implications of novel human acid sphingomyelinase splice variantsThe NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistanceCeramide-mediated insulin resistance and impairment of cognitive-motor functionsNitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's diseaseNitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.Mechanistic understanding of nanoparticles' interactions with extracellular matrix: the cell and immune systemSphingolipids in obesity, type 2 diabetes, and metabolic disease.High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism.Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitisMetabolic remodeling of white adipose tissue in obesityEffects of endurance exercise and high-fat diet on insulin resistance and ceramide contents of skeletal muscle in sprague-dawley ratsRole of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet.Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide.Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesImpact of nutrient excess and endothelial nitric oxide synthase on the plasma metabolite profile in mice.Relationships between fat deposition in the liver and skeletal muscle and insulin sensitivity in Japanese individuals: a pilot study.Coordinated and interactive expression of genes of lipid metabolism and inflammation in adipose tissue and liver during metabolic overload.NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases.NLRP3 inflammasomes link inflammation and metabolic disease.Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease.Mechanisms of ceramide-mediated neurodegeneration.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedCeramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complexHigh-Fat, High-Calorie Diet Enhances Mammary Carcinogenesis and Local Inflammation in MMTV-PyMT Mouse Model of Breast CancerSphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance.Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue.Increased bioactive lipids content in human subcutaneous and epicardial fat tissue correlates with insulin resistanceMacrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity.A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents.Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity.Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's diseasePalmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity.Roles and regulation of secretory and lysosomal acid sphingomyelinase.Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.
P2860
Q24648112-BDD49925-5E6E-424A-84E0-445F24A5BDDEQ26773230-A5476E1C-811B-4D02-9812-2ECB17A386B0Q28078340-80603142-4B96-4B5B-BD6C-64C715F80CEAQ28482775-DE60E706-7C0A-4F87-B3C8-2580B48DD55AQ29616026-1C477503-B6FD-48BE-818C-193EC5724DABQ30478907-12CEE9B3-4238-4DA7-9956-FB704A94D6BAQ30479198-79CF5EE1-FAE7-4EF9-9C14-7844584DDEDAQ30484122-5D952F05-3C8B-493D-A42F-33BA75F0CD0FQ33522880-45D16C9E-569D-4A5F-9510-5D37B4D831C7Q33543381-2A516665-CCFC-4CAC-A72F-B7BA3DE7DB25Q33831191-2194484E-6511-42D6-9AEC-F76BAC8A5014Q33880588-97C3A704-2352-4BC4-85BC-C09A8B2D3D6CQ33896110-A684DB73-4F08-4AC7-9CAD-5E468525FADAQ33944689-365222F0-DED2-438F-9F76-D1A85793B628Q34001327-AF3BECCC-98D8-4FE1-A915-B2C76DBBDCDDQ34101886-8FF492F9-1167-4EE1-B771-38A842F545D2Q34128783-CF709679-2FD8-4182-812D-3C911273D5CEQ34269858-258F10F3-47A2-4802-BBE8-B5334CAEAA0CQ34288447-683A4C42-72DC-47CD-8BA9-6FC47CD77675Q34569354-59C9CF65-BCCA-4BD2-A115-5A5FA80925E1Q34721267-9A6DBA73-E867-48BE-BC49-00EF857C412DQ35005525-1C115878-058F-4F16-9D18-F0E0A36FF4E6Q35045146-C31A2B97-69B9-4D70-A12D-FC3099CB65E8Q35151726-2D203ECD-A49B-44EB-85B7-12B412A627D6Q35227175-BD9BAB1B-21DF-4E58-8062-80B6E8C86467Q35433358-846E5703-0973-4C7E-A8B2-E83237B91F61Q35997878-EF58BAD4-EE2C-42D5-94B1-B4F876B13F33Q35997884-99BD8AD1-E33D-4468-9BA1-7A711C1A4874Q36047487-A7ECD9F2-4B1A-46A8-BBA7-49DFB372DA50Q36102802-E6914CB1-5003-4969-8446-B6335F2AD090Q36237414-21843A62-FCDF-4934-8069-43B28576BF71Q36338624-51D358A3-EA17-42DE-85FF-260EF4A9C4E4Q36408359-144ABADF-9524-48DC-AA8D-04A6E5B05035Q36444070-D0E35E28-A385-44B9-A764-58512828A9BAQ36608773-1DD73570-3C04-47EE-A6FE-3D16D4B50D8AQ36727429-607E9163-F8F7-4AB9-8829-09BF6BE9E2FEQ36836935-4B8B0EB4-C29E-49A8-A9BA-55532A967E99Q37299866-322B51F3-4404-48BA-8749-7F83C4A60D57Q37454661-C857DFBB-61E4-4302-9084-25B291B51B68Q37602608-E86BFB04-9FC6-4E8A-939E-C583A44D45FC
P2860
Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Protection from high fat diet- ...... minogen activator inhibitor 1.
@en
type
label
Protection from high fat diet- ...... minogen activator inhibitor 1.
@en
prefLabel
Protection from high fat diet- ...... minogen activator inhibitor 1.
@en
P2093
P2860
P356
P1476
Protection from high fat diet- ...... minogen activator inhibitor 1.
@en
P2093
Charmi Shah
Fahumiya Samad
Guang Yang
Jacek Bielawski
P2860
P304
13538-13548
P356
10.1074/JBC.M709950200
P407
P577
2008-03-22T00:00:00Z